Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Series A Convertible Preferred Stock [Member] Preferred Stock [Member]	Series B Preferred Stock [Member] Preferred Stock [Member]	Series C Convertible Preferred Stock [Member] Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2021				$ 1	$ 58,614,172	$ (65,703,954)	$ (7,089,781)
Balance (in shares) at Dec. 31, 2021				5,201
Issuance of common stock in public offering				$ 1	9,347,449		9,347,450
Issuance of common stock in public offering (in shares)				14,956
Issuance of common stock and exercise of pre-funded warrants in public offering				$ 7	9,999,989		9,999,996
Issuance of common stock and exercise of pre-funded warrants in public offering (in shares)				72,727
Offering costs					(2,921,646)		(2,921,646)
Common stock issued in connection with business combination					1,000,000		1,000,000
Common stock issued in connection with business combination (in shares)				3,636
Common stock issued pursuant to consulting agreement					123,000		123,000
Common stock issued pursuant to consulting agreement (in shares)				30
Warrant and common shares issued with notes					1,368,741		1,368,741
Warrant and common shares issued with notes (in shares)				2,400
Conversion of notes and derivative liability into common stock				$ 8	11,983,381		11,983,389
Conversion of notes and derivative liability into common stock (in shares)				79,807
Conversion of venture debt into Series A convertible preferred stock	$ 1				6,299,999		6,300,000
Conversion of venture debt into Series A convertible preferred stock (in shares)	6,300
Stock-based compensation					479,038		479,038
Net loss						(38,043,362)	(38,043,362)
Balance at Dec. 31, 2022	$ 1			$ 18	96,294,123	(103,747,316)	(7,453,174)
Balance (in shares) at Dec. 31, 2022	6,300			178,758
Stock-based compensation					408,810		408,810
Net loss						(10,247,133)	(10,247,133)
Issuance of common stock pursuant to private placement, net of offering costs				$ 5	4,463,071		$ 4,463,076
Issuance of common stock pursuant to private placement, net of offering costs (in shares)				51,086			1,277,140
Shares and warrants issued with notes					658,494		$ 658,494
Shares and warrants issued with notes (in shares)				4,400
Conversion of notes into preferred stock			$ 1		5,759,177		5,759,177
Conversion of notes into preferred stock (in shares)			5,761
Issuance of Series B preferred stock					25,000		25,000
Issuance of Series B preferred stock (in shares)		1
Issuance of common stock pursuant to disposition				$ 8	1,357,035		1,357,043
Issuance of common stock pursuant to disposition (in shares)				78,103
Cancellation of Series B preferred stock					(25,000)		(25,000)
Cancellation of Series B preferred stock (in shares)		(1)
Common stock issued for services				$ 11	1,656,417		1,656,428
Common stock issued for services (in shares)				109,930
Exercise of warrants				$ 12	1,167,554		1,167,566
Exercise of warrants (in shares)				123,814
Issuance of common stock pursuant to private placement, net of offering costs				$ 51	3,832,254		3,832,305
Issuance of common stock pursuant to private placement, net of offering costs (in shares)				513,875
Conversion of preference shares into common stock				$ 5	(5)
Conversion of preferred shares into common stock (shares)			(975)	54,394
Balance at Dec. 31, 2023	$ 1		$ 1	$ 110	$ 115,596,929	$ (113,994,449)	$ 1,602,592
Balance (in shares) at Dec. 31, 2023	6,300		4,786	1,114,359